PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule ...
Q1 2026
May 8, 2026
FY 2025
Mar 6, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 7, 2025